Mark
3.2K posts

Mark
@PresMcCormack
I am your President, Podcaster and Investor
Los Angeles, CA Katılım Haziran 2012
254 Takip Edilen418 Takipçiler

@growthrapidly Waiting for a pullback unless I get allocation before.
English

@Vivek4real_ Because there are more sellers than buyers.
Price drops until another sucker is found.
The hype is over, crypto is annoying. Sell that fake asset and buy some gold/silver. 🤗
English

@townhallcom @LarryOConnor Why does the left always change terms? It makes them sound low IQ
English

.@LarryOConnor RIPS LA Mayor Karen Bass for focusing on the wrong part of the homelessness crisis:
"She says, 'Well, you try living on the street. You'll be a zombie, too.'
I got a better question: why don't you do something about it? Instead of, 'well, of course they're zombies. We're fine with that. I just don't want to use that word. It's mean. They're just unhoused.'
You know who else is unhoused? Spencer Pratt is unhoused, but he doesn't live on the sidewalk, does he?"
English

@Teslaconomics The stock price is wildly expensive for a company that has the potential to be the most impactful over the next 30 years. I am going to wait till the lock up periods are all done to buy. I will set a monthly allocation and dollar cost average into it for 3-4 years.
English

@bennyjohnson WTF
Why is Trump firing his best ppl? This is so fvcking stupid.
First Neom, then Bondi, and now Tulsi. This is moronic.
English

@paulsaladinomd They won’t gain it back if they change their eating habits while on it and chose to live a healthy live style. Right doctor?
English

Reta will likely become the #1 selling drug in the world.
Good news:
People will lose weight while they are on it. It may even help with addictions.
Bad news:
That weight will be regained when reta is stopped. Many may also lose interest in things they previously enjoyed due to GLP-1's role in pleasure pathways in the brain.
It surely helps people, but at what cost?
Bryan Johnson@bryan_johnson
These numbers are shocking. It's like we got a new frontier AI model but for the body. Lilly's phase 3 results for retatrutide: > highest dose lost 28.3% of body weight in 80 wks > 70 lbs ave > 45% lost 30% or more of their body weight > 65% on the top dose no longer clinically obese Retatrutide is more dynamic than semaglutide and tirzepatide because it targets three receptors (GIP, GLP-1, and glucagon), versus one and two, respectively. Side effects, on the highest dose (12mg), were higher for retatrutide than tirzepatide (nausea and GI), with an 11.3% drop out rate. The lowest 4mg dose still delivered 19% loss with fewer dropouts than placebo.
English

@PresMcCormack @AlphaOwlTrading All those guys beat the S&P for 40 straight years
English

@VJNCapital It’s a bad company and service. A bunch of anonymous profiles talking crap to each other. Tons of porn. Tons of misinformation. Differing opinions get you voted down so mob rules. Buy great companies. This won’t do better then $META over a 10 year period.
English























